Status:
UNKNOWN
A Multicenter Prospective Study of "High Risk" Molecular Typing in Patients With Adult T Lymphoblastic Lymphoma
Lead Sponsor:
Sun Yat-sen University
Conditions:
T-Lymphoblastic Lymphoma/Leukemia
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the indicative value of "high risk" molecular typing in patients with adult T lymphoblastic lymphoma
Eligibility Criteria
Inclusion
- biopsy proved T lymphoblastic lymphoma
- newly diagnosed patients
Exclusion
- patients with biopsy samples unavailable
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2023
Estimated Enrollment :
207 Patients enrolled
Trial Details
Trial ID
NCT04320992
Start Date
March 1 2020
End Date
March 1 2023
Last Update
March 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University,
Guangzhou, China, 51000